Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.680
+0.310 (9.20%)
At close: May 12, 2025, 4:00 PM
3.500
-0.180 (-4.89%)
After-hours: May 12, 2025, 5:15 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $148.15 million as of May 12, 2025. Its market cap has decreased by -49.24% in one year.
Market Cap
148.15M
Enterprise Value
116.39M
1-Year Change
-49.24%
Ranking
Category
Stock Price
$3.68
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $148.15M, a decrease of -88.89%. That is a compound annual growth rate of -37.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 135.67M | -49.40% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |